TipRanks on MSN
Neurogene Begins Dosing in Rett Syndrome Trial
Neurogene ( ($NGNE) ) just unveiled an update. On November 6, 2025, Neurogene Inc. announced the dosing of the first participant in the Embolden™ ...
TipRanks on MSN
Neurogene doses first patient in NGN-401 clinical trial
Neurogene (NGNE) announced that the first participant was dosed in the Embolden registrational clinical trial of NGN-401, a gene therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback